Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma

IntroductionUveal melanoma (UM) is the most common primary intraocular malignant tumor in adults, and the main treatment for UM is currently surgery and plaque brachytherapy. UM is highly susceptible to metastasis, which eventually occurs in nearly half of all patients; once metastasis occurs, patie...

Full description

Bibliographic Details
Main Authors: Yuanyuan Hu, Jiayang Cai, Meng Ye, Qianxue Mou, Bowen Zhao, Qian Sun, Xiaotong Lou, Hong Zhang, Yin Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
immunogenic cell death
uveal melanoma
prognosis
immune landscape
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1037128/full

Similar Items

Similar Items